# Sixty years of conjecture over a urinary biomarker: a step closer to understanding the proposed link between anxiety and urinary pyrroles

**Authors:** Angela Sherwin, Ian C Shaw

PMC · DOI: 10.1093/labmed/lmad086 · 2023-09-12

## TL;DR

This study investigates a long-debated urinary biomarker linked to anxiety, narrowing down its identity and exploring its potential biological origins and effects.

## Contribution

The study identifies kryptopyrrole as a likely candidate for the elusive Mauve Factor and explores its possible biological mechanisms.

## Key findings

- Hydroxypyrrole is ruled out as Mauve Factor based on Ehrlich’s reaction chemistry.
- Kryptopyrrole concentrations in urine are similar between anxious and non-anxious individuals.
- Kryptopyrrole may originate from stercobilin and interact with GABA receptors and zinc homeostasis.

## Abstract

For over 60 years there has been conjecture about the identity of an Ehrlich’s test positive pyrrole (Mauve Factor) reputed to be a biomarker for psychological disorders, including anxiety. We reviewed studies that attempt to identify Mauve Factor and subjected authentic standards of the 2 main candidates, kryptopyrrole and hydroxypyrrole, to the Ehrlich’s reaction.

Modified Ehrlich’s test for kryptopyrrole and hydroxypyrrole were applied to urine samples from 10 volunteers, anxious and nonanxious.

Based on the mechanistic chemistry of Ehrlich’s reaction and reactions of the 2 compounds, Mauve Factor cannot be hydroxypyrrole. Analyses of urine samples from volunteers, identified by the Generalized Anxiety Disorder - 7 item scale (GAD-7 ≥10; n = 5) and control urine samples (GAD-7 <10; n = 5) using a kryptopyrrole calibration graph, show that concentrations are similar in both groups.

Kryptopyrrole may be the elusive Mauve Factor. Its possible origin from stercobilin via gut microbiome–mediated metabolism, its link to gut-mediated neurological effects via γ-aminobutyric acid (GABA) receptors, and its predicted interaction with Zn2+ and consequent impact on zinc homeostasis are discussed. The GAD-7 scale does not differentiate between state and trait anxiety and as such, the minimal difference in pyrrole levels between volunteer groups requires further study.

## Linked entities

- **Chemicals:** kryptopyrrole (PubChem CID 10600), hydroxypyrrole (PubChem CID 13795005), stercobilin (PubChem CID 44457542), γ-aminobutyric acid (PubChem CID 119), Zn2+ (PubChem CID 32051)
- **Diseases:** anxiety (MONDO:0005618), Generalized Anxiety Disorder (MONDO:0001942)

## Full-text entities

- **Diseases:** psychological disorders (MESH:D000067073), anxiety (MESH:D001007), Generalized Anxiety Disorder (MESH:C000726808), GAD-7 (MESH:C537955)
- **Chemicals:** pyrrole (MESH:D011758), stercobilin (MESH:C002298), Kryptopyrrole (MESH:C011891), Zn2+ (-)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11064097/full.md

---
Source: https://tomesphere.com/paper/PMC11064097